Lumida
/BHF
⌘K
Brighthouse Financial Inc

Brighthouse Financial Inc

BHF
$50.11USD-1.44%-0.73 today

MARKET CAP

2.9B

P/E (TTM)

8.6x

FWD P/E

DAY RANGE

$50 – $51

52W RANGE

$45
$67

The case for & against

Bull & Bear analysis

Bearish

Brighthouse Financial (NASDAQ: BHF) is a leading player in the life insurance sector, focusing on annuities, particularly its innovative SHIELD product. The company provides comprehensive financial protection solutions and is strategically positioned in the market to benefit from increasing annuity sales driven by shifting consumer preferences toward retirement income products. Their business model aims at enhancing capital efficiency while managing risks associated with their variable annuity offerings amidst evolving regulatory frameworks.

Bull says

  • Q2 2024 SHIELD sales $2 B, YTD $7.7 B (+12% YoY) highlights market leadership
  • Favorable interest-rate sensitivity to rising bond yields could boost annuity margins
  • $250 M in share buybacks YTD underscores proactive capital management
  • ~$1.3 B in liquid assets ensures flexibility for growth and shareholder returns
  • Median analyst price target $59.76 implies upside; initiatives aim to improve RBC
  • High earnings yield and attractive book-to-price ratio signal value

Bear says

  • RBC ratio at ~380–400% vs 400–450% target raises regulatory risk
  • Negative growth and profitability factors suggest earnings weakness
  • Q2 adjusted earnings $198 M (~23% below run rate) reflect margin compression
  • Rising compliance costs and product complexity threaten future profitability
  • Consensus hold rating and negative quality factors underscore investor caution
  • Analyst revision trends point to lowered profit forecasts

Investment themes with BHF

L&H Insurance -0.09%

PGR · TRV · ALL

Earnings Call · Q2 2024 · Mgmt. Guidance

Updated 09-14-2026neutral

Transcript signals

Bull points

  • In the second quarter, corporate expenses were $200 million, bringing year-to-date corporate expenses through June 30th to $407 million, which is approximately 6% lower compared with the same period in 2023. While we expect expenses to increase in the second half of 2024, we still anticipate full-year 2024 corporate expenses to be lower than full-year 2023 corporate expenses.
  • I'm proud of the success of our distribution franchise. The second quarter sales results further demonstrate our complimentary and diversified suite of annuity and life insurance products. Year to date through June 30th, total annuity sales were $5.3 billion, consistent with the same period in 2023. We remain a leader in the registered index-linked annuity market with record sales of our SHIELD annuities, which exceeded $2 billion in the quarter.
  • Year-to-date SHIELD sales exceeded $3.9 billion, a record level for the first half of the year, and an increase of 23% over the same period in 2023.

Bear points

  • 70% roughly of this norm stat loss would be what I would call something that was not anticipated. Now, we do anticipate basis risk, but we anticipate that over time it's zero. So it was negative, and that is why I would throw it in that 70% of the performance here.
  • it wouldn't be surprising to you, I don't think, to assume that if we're worried a little bit about credit, we probably weren't overly excited about the equity market.
  • I would say that we have tactically been more conservative on big equity market down moves. than what I would consider to be our normal strategic positioning. So that has cost us some norm stat earnings in 2023 and year to date 2024.
Read full transcript analysis ›